AAVEBTC moved up multiple levels in January and has stablished a new support.
We can see a low hit mid-April when MA200 was tested as support.
In late June just by a few satoshis we now have a higher low.
With prices moving back above MA200, a bullish cross on the MACD and a strong RSI... Prices can resume it's growth.
Generally, we first aim at the upper part of the channel (blue trendlines), but this can end in a higher high as we are bullish here overall.
Thanks a lot for your support.
Namaste.
We can see a low hit mid-April when MA200 was tested as support.
In late June just by a few satoshis we now have a higher low.
With prices moving back above MA200, a bullish cross on the MACD and a strong RSI... Prices can resume it's growth.
Generally, we first aim at the upper part of the channel (blue trendlines), but this can end in a higher high as we are bullish here overall.
Thanks a lot for your support.
Namaste.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.